Stocks
Lucid Diagnostics Inc.LUCD
NASDAQHealthcareDiagnostics$0.51
Price as of · delayed, not real-time
A developer of diagnostic testing products, Lucid Diagnostics Inc. focuses on non-invasive screening technologies for early disease detection. The company's proprietary assays target specific biomarkers, positioning it in the growing molecular diagnostics market. Investors track LUCD for its potential in the preventive healthcare segment.
52W Range: $0.30-$1.63
Congressional Interest in Lucid Diagnostics Inc. (LUCD)
No congressional trades have been disclosed for Lucid Diagnostics Inc. (LUCD) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading LUCD?
No congressional trades found for this stock.